Nifedipine-maintained tocolysis no benefit in perinatal outcomes

Nifedipine-maintained tocolysis no benefit in perinatal outcomes
For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue of the Journal of the American Medical Association.

(HealthDay)—For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue of the Journal of the American Medical Association.

Carolien Roos, M.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues conducted a randomized, double-blind, placebo-controlled study in 11 perinatal units in all tertiary centers in the Netherlands to examine whether maintenance tocolysis with nifedipine would reduce adverse perinatal outcome linked to premature birth. with threatened preterm labor between 26 and 32 weeks of gestation, who had not delivered after 48 hours of tocolysis and a completed course of corticosteroids, were randomized to oral nifedipine (201 women) or placebo (205 women) for 12 days. Surviving infants were followed for six months.

The researchers observed no significant between-group difference in adverse perinatal outcome (11.9 percent for nifedipine versus 13.7 percent for placebo; relative risk, 0.87; 95 percent confidence interval, 0.53 to 1.45).

"It seems likely that the absence of any effect is not due to ineffectiveness of nifedipine as a uterine relaxant," the authors write. "Apparently, symptomatic treatment of uterine contractions with any uterine relaxant is ineffective when used as . The etiology of threatened preterm labor is multifaceted and includes subclinical intrauterine infection. Future research should be directed toward therapies tailored to the specific underlying causes of ."

One author disclosed a financial tie to CSL Behring, and one author reported provision of expert testimony to courts, payment for lectures, and private/unrelated stock/stock options.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

No increase in preterm delivery with Ramadan fasting

date Aug 07, 2012

(HealthDay) -- Pregnant women who fast during the month of Ramadan do not have an increased risk of preterm delivery, regardless of when during gestation the fasting occurs, according to research published ...

Recommended for you

Self-hypnosis training doesn't cut epidural use

date May 26, 2015

(HealthDay)—Self-hypnosis training does not reduce women's epidural use during childbirth, according to a study published online May 11 in BJOG: An International Journal of Obstetrics and Gynaecology.

ACOG urges expedited partner therapy for some STIs

date May 25, 2015

(HealthDay)—For patients with sexually transmitted infections (STIs), such as gonorrhea and chlamydia, whose partners are unable or unwilling to seek care, expedited partner therapy can be used to prevent ...

German woman, 65, gives birth to quadruplets

date May 23, 2015

A 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticized by medical professionals because of her age, RTL television said Saturday.

More evidence C-sections riskier for moms

date May 20, 2015

(HealthDay)—Women who deliver their first baby by cesarean section are more likely to need blood transfusions and be admitted to intensive care units than women who opt for a vaginal delivery, U.S. health ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.